Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7771 AL 7785

Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials

Zimmer JA, Ardayfio P, Wang H, Khanna R, Evans CD, Lu M, Sparks J, Andersen S, Lauzon S, Nery ESM, Battioui C, Engle SE, Biffi A, Svaldi D, Salloway S, Greenberg SM, Sperling RA, Mintun M, Brooks DA, Sims JR.

JAMA Neurol. 2025 May 1;82(5):461-469. doi: 10.1001/jamaneurol.2025.0065.

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease

Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, Johannsen P, León T, Scheltens P.

Alzheimers Res Ther. 2025 Jan 8;17(1):14. doi: 10.1186/s13195-024-01666-7.

[Observational study on the coincidence of Alzheimer's disease and idiopathic normal pressure hydrocephalus: analysis of coincidence, the influence on response to cerebrospinal fluid drainage and cerebrovascular copathology]

Beeke M, Sauer C, Petzold J, Schneider S, Frenzen K, Donix M, Reiß G, Brandt M, Haußmann R.

Nervenarzt. 2025 Dec;96(7):686-695. doi: 10.1007/s00115-025-01808-8. Epub 2025 Feb 27.

Lucid episodes among people with Alzheimer's disease and related dementias and their impact on family caregiver stress and grief (LEAD): protocol for a longitudinal observational study

Griffin JM, Bangerter LR, Kim K, Liu Y, Batthyány A, Birkeland RW, Frangiosa TL, Nosheny RL, Gaugler J, Lapid MI.

BMJ Open. 2025 Jul 10;15(7):e098182. doi: 10.1136/bmjopen-2024-098182.

Addressing the knowledge and recruitment gap in Alzheimer's disease and precision medicine research among Native people: an innovative randomized controlled trial

Hebert LE, Kulbacki-Fabisiak C, Muller C, Boyd A, O'Leary M, Poole E, Ramos M, Barker D, Sinclair K, Manson SM, Buchwald D.

Ethn Health. 2025 May;30(4):471-490. doi: 10.1080/13557858.2025.2479456. Epub 2025 May 7.

Regional disparities of antidementia drug treatment in Germany: what can we learn for the new generation of Alzheimer's therapies

Platen M, Gläser E, Dahling V, Gesell D, Hauptmann M, Horenkamp-Sonntag D, Koller D, Kubat D, Marschall U, Riederer C, Scheibner H, Schroth J, Swart E, Michalowsky B.

Alzheimers Res Ther. 2025 Dec 4;17(1):259. doi: 10.1186/s13195-025-01902-8.

Validity of gold-standard clinical outcome assessments in U.S. Latinx-Hispanic participants enrolled in Alzheimer's disease clinical trials: A literature review

Monserratt LH, Morales JA, Mohammed A, Ovalle-Eliseo S, Islas-Huerta G, Perez LA, Díaz-Santos M.

Alzheimers Dement. 2025 Dec;21(12):e70918. doi: 10.1002/alz.70918.

Annual societal cost of Alzheimer's disease in Malaysia: a micro-costing approach

Ong SC, Tay LX, Ong HM, Tiong IK, Ch'ng ASH, Parumasivam T.

BMC Geriatr. 2025 Mar 6;25(1):154. doi: 10.1186/s12877-025-05717-y.

Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?

Davidson M, Stanciu GD, Rabinowitz J, Untu I, Dobrin RP, Tamba BI.

Dialogues Clin Neurosci. 2025 Dec;27(1):1-12. doi: 10.1080/19585969.2025.2480566. Epub 2025 Mar 19.

Association between comorbidity indices and nursing home admission in patients with Alzheimer's disease: a longitudinal observational study using the MEMORA cohort

Temedda MN, Garnier-Crussard A, Moutet C, Mouchoux C, Dauphinot V.

BMC Geriatr. 2025 Apr 16;25(1):254. doi: 10.1186/s12877-025-05898-6.

Unveiling Alzheimer's disease (1901-2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies

Baviskar PS, Mahajan HS.

Ageing Res Rev. 2026 Jan;114:102990. doi: 10.1016/j.arr.2025.102990. Epub 2025 Dec 10.

Feasibility and acceptability of a telephone-based ACT intervention for caregivers (TACTICs) of adults with Alzheimer's disease and related dementias (ADRD): a randomized pilot during the COVID-19 pandemic

Hockemeyer NG, Johns SA, Judge KS, Baucco C, Gowan T, Slaven JE, Fowler NR.

Aging Ment Health. 2025 Apr;29(4):639-650. doi: 10.1080/13607863.2025.2453823. Epub 2025 Jan 21.

The effects of transcranial direct current stimulation on global cognition in patients with Alzheimer's disease: An update meta-analysis

Su S, Huang R, Liu Y.

J Alzheimers Dis. 2025 Jan;103(1):19-37. doi: 10.1177/13872877241298303. Epub 2025 Jan 9.

Virtual reality interventions and their effects on the cognition of individuals with Alzheimer's disease: A systematic review and meta-analysis

Santos VD, Costa AC, Junior NC, Delaere FJ, Serlet S, Dourado MCN.

J Alzheimers Dis. 2025 Jan;103(1):68-80. doi: 10.1177/13872877241299037. Epub 2024 Nov 25.

Conventional and Emerging Drug Targeting Sites in Alzheimer's Disease and the Role of Translational Informatics in its Diagnosis and Management

Khan KA, Esa M, Kamal Z, Ullah B, Perry G, Kamal S, Ahmad S, Hussain H, Ullah A, Shafique M.

Curr Neuropharmacol. 2025;23(14):1894-1917. doi: 10.2174/011570159X361867250313073624.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias